HomeXERS • NASDAQ
add
Xeris Biopharma Holdings Inc
Previous close
$6.02
Day range
$5.73 - $6.00
Year range
$3.59 - $10.08
Market cap
985.59M USD
Avg Volume
1.81M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 85.81M | 42.78% |
Operating expense | 58.09M | 35.58% |
Net income | 11.08M | 316.72% |
Net profit margin | 12.91 | 251.70% |
Earnings per share | 0.06 | 300.00% |
EBITDA | 19.82M | 83.49% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 111.04M | 55.04% |
Total assets | 383.53M | 18.72% |
Total liabilities | 369.84M | 4.87% |
Total equity | 13.69M | — |
Shares outstanding | 172.43M | — |
Price to book | 75.25 | — |
Return on assets | 11.13% | — |
Return on capital | 15.87% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 11.08M | 316.72% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2005
Headquarters
Website
Employees
394
